ISSN 1016-5169 | E-ISSN 1308-4488
HOME
CONTACT
TR
Toggle navigation
ABOUT
Abstracting and Indexing
Bibliographic Details
50th Volume
Copyright
AIM AND SCOPE
EDITORIAL BOARD
INSTRUCTIONS FOR AUTHORS
CONTACT
Archives of the Turkish Society of Cardiology
ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY
Volume 48 | Issue 7 | October 2020
Front Matter | Content
COVID-19 and RAAS blockers: Could Aliskiren be an appropriate option? [Turk Kardiyol Dern Ars]
Turk Kardiyol Dern Ars. 2020; 48(7):
631-634 | DOI:
10.5543/tkda.2020.64072
COVID-19 and RAAS blockers: Could Aliskiren be an appropriate option?
Selçuk Şen
,
Ali Yağız Üresin
Department of Medical Pharmacology, Division of Clinical Pharmacology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey
Keywords:
COVID-19, ACE inhibitor, angiotensin receptor blocker, direct renin inhibitor, aliskiren
Corresponding Author:
Selçuk Şen, Türkiye
Manuscript Language:
English
×
APA
NLM
AMA
MLA
Chicago
Copy
Copied!
CITE
English Full Text
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Send email to author
Similar articles
PubMed
Google Scholar